AMCP joins 17 other health care organizations and consumer groups in support of the Fair Access for Safe and Timely “FAST” Generics Act of 2017 – H.R. 2051. This bipartisan legislation is designed to increase access to generic and biosimilar medications.
AMCP joins 17 other health care organizations and consumer groups in support of the Fair Access for Safe and Timely “FAST” Generics Act of 2017 – H.R. 2051. This bipartisan legislation is designed to increase access to generic and biosimilar medications.